ACROMEGALY TREATMENT MARKET ANALYSIS

Acromegaly Treatment MarketSize and Trends

Market Size According to the American Society of Clinical Oncology (ASCO), 14,230 individuals of the U.S. were diagnosed with pituitary gland tumor in 2017, of which majority are benign tumor. Furthermore, in 2017, the National Organization for Rare Disorders estimated the prevalence rate of acromegaly as 50-70 person per million and 3 new cases occurs per million every year, which is expected to increase the demand for acromegaly treatment market.

Acromegaly Treatment Market Dynamics:

By Disease Type:

• Ectopic Acromegaly
• Pseudo Acromegaly

By Drug Class:

• Somatostatin Analogs (SSAs)
• Somatuline Depot (Lanreotide)
• Others SSAs
• Dopamine Agonists (DAs)
• Bromocriptine Mesylate (Parlodel)
• Others DAs
• Growth Hormone Receptor Antagonist (GHRAs)
• Somavert (Pegvisomant)

By Route of Administration:

• Oral
• Parenteral

By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies